Technical Analysis for ERYP - Erytech Pharma S.A.

Grade Last Price % Change Price Change
grade D 8.47 -5.99% -0.54
ERYP closed down 5.99 percent on Monday, March 18, 2019, on 3 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical ERYP trend table...

Date Alert Name Type % Chg
Mar 18 Fell Below 20 DMA Bearish 0.00%
Mar 18 Narrow Range Bar Range Contraction 0.00%
Mar 18 Gapped Down Weakness 0.00%
Mar 15 Pocket Pivot Bullish Swing Setup -5.99%
Mar 15 Narrow Range Bar Range Contraction -5.99%
Mar 15 Gapped Up Strength -5.99%
Mar 15 Up 3 Days in a Row Strength -5.99%
Mar 14 MACD Bearish Signal Line Cross Bearish -4.51%
Mar 14 Calm After Storm Range Contraction -4.51%
Mar 14 Narrow Range Bar Range Contraction -4.51%

Older signals for ERYP ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer. The Company's technology is based on the use of human red blood cells (RBCs) to improve the pharmacokinetic (PK) and pharmacodynamic (PD) properties of therapeutic enzymes, for instance asparaginase. The enzyme can destroy asparagine and deprive cancer cells of an important nutrient for these cells, resulting in their death. The Company's subsidiary is Erytech Pharma, Inc in the USA which legal existence began in April 9, 2014.
Medicine Biopharmaceutical Cancer Clinical Medicine Antineoplastic Drugs Leukemia Acute Lymphoblastic Leukemia Asparaginase Medicinal Products
Is ERYP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 23.46
52 Week Low 5.45
Average Volume 3,564
200-Day Moving Average 11.7194
50-Day Moving Average 7.9669
20-Day Moving Average 8.6851
10-Day Moving Average 9.0463
Average True Range 0.3757
ADX 25.65
+DI 48.7811
-DI 35.9721
Chandelier Exit (Long, 3 ATRs ) 9.5229
Chandelier Exit (Short, 3 ATRs ) 8.7271
Upper Bollinger Band 9.6258
Lower Bollinger Band 7.7444
Percent B (%b) 0.39
BandWidth 21.662387
MACD Line 0.2221
MACD Signal Line 0.2805
MACD Histogram -0.0584
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.47
Resistance 3 (R3) 8.47 8.47 8.47
Resistance 2 (R2) 8.47 8.47 8.47 8.47
Resistance 1 (R1) 8.47 8.47 8.47 8.47 8.47
Pivot Point 8.47 8.47 8.47 8.47 8.47
Support 1 (S1) 8.47 8.47 8.47 8.47 8.47
Support 2 (S2) 8.47 8.47 8.47 8.47
Support 3 (S3) 8.47 8.47 8.47
Support 4 (S4) 8.47